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Abstract
Background: Stenotrophomonas maltophilia is inherently resistant to many antimicrobials. So far,
antimicrobial susceptibility tests for S. maltophilia have not been fully standardized. The purpose of
the study was to compare the susceptibility of S. maltophilia isolates against seven different
antimicrobials using three different methods and to investigate their genetic relatedness.
Results: Although trimethoprim/sulfamethoxazole (SXT) and ciprofloxacin have the lowest MIC
values, SXT (98.1%) and ticarcillin/clavulanate (TLc) (73.1%) were found to be the most effective
antimicrobials by agar dilution method, which was in accordance with the breakpoints established
by NCCLS. Disc diffusion and E-test was in agreement with agar dilution method for SXT. When
the isolation dates, clinics, antibiotyping, and AP-PCR data were investigated, two small outbreaks
consisting of five and three cases were determined.
Conclusion: By using the NCCLS criteria, disc diffusion and E-test were unreliable alternative
methods for S. maltophilia, except for SXT. However, the significance of these data should be
confirmed by further experimental and clinical studies.
Background
Infections with Stenotrophomonas maltophilia are increas-
ingly encountered especially in debilitated or immune
suppressed patients [1,2]. Nosocomial infections of the
respiratory, urinary, central nervous, musculoskeletal,
skin-soft tissue systems and of the gastrointestinal tract,
and bacteremia, endocarditis and eye infections occur in
sensitive individuals [2-4].
S. maltophilia is inherently resistant to many antimicrobi-
als. Additional resistance develops against cephalosporins
and aminoglycosides because of decreased outer mem-
brane permeability and via at least two types of beta-lacta-
mases [5]. Recently, resistance to floroquinolones via
efflux system has been reported [6]. Also, antimicrobial
susceptibility tests for S. maltophilia have not been so far
fully standardized [2]. These problems raise difficulties for
the choice of antimicrobials in S. maltophilia infections.
In this study, disc diffusion and E-test methods were com-
pared with the agar dilution method in S. maltophilia
strains against seven different antimicrobials. We also
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investigated the genetic relatedness of S. maltophilia iso-
lates by the arbitrarily primed PCR (AP-PCR).
Results
S. maltophilia strains were mostly isolated from the lower
respiratory tract (n = 20), and from urine (n = 11) and
blood (n = 7) samples, and the majority were from the
clinics of Paediatrics (n = 14), Neurology (n = 9), Neph-
rology (n = 8), Chest Diseases (n = 4) and Intensive Care
Units (n = 4). Only six strains were isolated in 1998; how-
ever the isolation rate steadily increased throughout the
years and reached 17 strains in 2002. In particular, the
annual isolation rate in the clinics of Paediatrics and Neu-
rology was only one or two until 2001, however it
increased to six in 2001 and five in 2002 in Paediatrics.
Also, six strains were isolated in Neurology in 2002.
Although trimethoprim/sulfamethoxazole (SXT) and cip-
rofloxacin (CIP) have the lowest minimal inhibitory con-
centration (MIC) values, the most effective antimicrobials
were SXT and ticarcillin/clavulanate (TLc), which was in
accordance with the breakpoints established by The
National Committee for Clinical Laboratory Standards
(NCCLS). The rate of susceptibilities obtained by the disc
diffusion and E-test methods were similar to the agar dilu-
tion test; however, false susceptibility for CIP by both tests
(p < 0.001) and for TLc by the E-test were obtained (p <
0.04) (Table 1). The disc diffusion and E-test methods
showed a good agreement with agar dilution method for
SXT (Table 2). Rates of correlations were poor for the
other antimicrobials.
A total of 44 different patterns of 52 strains were obtained
by The arbitrarily primed PCR (AP-PCR). Three small clus-
ters were observed. All of five strains in pattern l were iso-
lated in the Neurology clinic between March and
September 2002. All three strains in pattern ll were iso-
lated in the Paediatrics clinic between January and March
2001, and three strains in pattern lll were isolated in the
Paediatrics, Nephrology and Chest Diseases clinics
between January and November 2001. The antimicrobial
susceptibility results supported the AP-PCR method for
Table 1: Susceptibility of S. maltophilia obtained by the three methods studied (N = 52)
Percentage susceptibility* Agar MIC (mg/L)
Agent Disc diffusion E Test Agar dilution (MIC breakpoint) MIC50 MIC90 MIC Range
Ceftazidime 67.3 63.5 50.0 (≤  8 mg/L) 8 256 0.25->256
Cefepime 30.8 42.3 34.6 (≤  8 mg/L) 16 64 1–64
Piperacillin 34.6 15.4 26.9 (≤  16 mg/L) 64 256 1->256
PTZ 61.5 46.2 42.3 (≤  16/4 mg/L) 32/4 128/4 4/4->256/4
TLc 84.6 90.4 73.1 (≤  16/2 mg/L) 8/2 64/2 0.5/2->256/2
Ciprofloxacin 92.3 92.3 53.8 (≤  1 mg/L) 1 4 0.5–16
SXT 98.1 98.1 98.1 (≤  2/38 mg/L) 0.5/9.5 1/19 0.125/2.375- 128/2432
PTZ: Piperacillin/tazobactam, TLc: Ticarcillin/clavulanate, SXT: Trimethoprim/sulfamethoxazol
Table 2: Correlation of susceptibility test methods for 52 S. maltophilia strains
% Discrepance
Very Major Major Error Minor Error % Correlation
N = 52 Agar-disc Agar-E-test Agar-disc Agar-E-test Agar-disc Agar-E-test Agar-disc Agar-E-test
Ceftazidime 5.8 5.8 0 0 17.3 13.4 76.9 80.8
Cefepime 0 1.9 0 0 11.5 23.1 88.5 75.0
Piperacillin 0 0 1.9 1.9 38.5 38.5 59.6 59.6
P T Z 1 . 9 0 0 1 . 9 3 4 . 62 3 . 16 3 . 57 5 . 0
T L c 0 1 . 9 1 . 9 0 1 7 . 31 9 . 28 0 . 87 8 . 9
Ciprofloxacin 5.8 5.8 0 0 32.7 32.7 61.5 61.5
S X T 000000 1 0 0 1 0 0
PTZ: Piperacillin/tazobactam, TLc: Ticarcillin/clavulanate, SXT: Trimethoprim/sulfamethoxazoleBMC Microbiology 2005, 5:24 http://www.biomedcentral.com/1471-2180/5/24
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AP-PCR profiles of S. maltophilia strins including statistical analysis and dendrogram showing the genetic relationship between  strains Figure 1
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patterns l and ll, but not for pattern III. The strains in pat-
tern I were resistant to ceftazidime (CAZ), cefepime
(CPM), piperacillin (PIP) and piperacillin/tazobactam
(PTZ), and susceptible to TLc, CIP, and SXT. The strains in
pattern II were susceptible to all antimicrobial except for
CIP. The dendrogram showed a Dice similarity coefficient
ranging from14.8 to 100% (Figure 1).
Discussion
S. maltophilia has low pathogenicity, but it has emerged as
an important nosocomial pathogen. Patients infected
with S. maltophilia usually have underlying immunodefi-
ciency or history of long-term or multiple hospitaliza-
tions, exposure to invasive devices and/or broad spectrum
antimicrobials [2]. This organism, most frequently, causes
lower respiratory and urinary tract infections and may
result in secondary bacteremia [2]. Our results supported
these observations.
According to the recommendations of the NCCLS [7,8],
agar dilution method should be used in order to detect
antimicrobial susceptibility of S. maltophilia strains. Since
the dilution methods are more cumbersome or expensive
than the disc diffusion or E-test methods in routine clini-
cal microbiology laboratories, the aim of this study was to
compare the performance of these latter methods with
agar dilution method.
The NCCLS had not defined the criteria for disc diffusion
method for S. maltophilia by the year 2004. So, break-
points for other bacteria from the NCCLS comments have
been tried to be adapted in various studies [6,14]. The best
correlated results have been obtained with those recom-
mended for Pseudomonas aeruginosa [6]. In 2004, the
NCCLS recommended disc diffusion breakpoints for
minocycline, levofloxacin, and SXT. Nevertheless, we
tested other antimicrobials frequently used in nosocomial
infections and interpreted these antimicrobial susceptibil-
ities using the NCCLS criteria established for P. aeruginosa.
Our results showed that the most effective antimicrobials
against S. maltophilia were SXT and TLc, as observed by
several authors [6,14]. Nevertheless, the resistance rates
for other antimicrobials in our study were extremely high.
Resistance to beta-lactams in S. maltophilia is primarily
intrinsic and mediated by inducible beta-lactamases (L1
and L2) that hydrolyses virtually all classes of beta-
lactams [2]. Although many authors have tested piperacil-
lin (with or without tazobactam) and cefepime against S.
maltophilia, they are not suitable for the treatment of S.
maltophilia infections. L2 beta-lactamase is susceptible to
clavulanic acid, so TLc is preferred to PTZ [2,15]. How-
ever, Carrol et al. [1] determined that there was an obvi-
ous increase in the level of resistance to TLc when they
prolonged the susceptibility tests up to 48 hours. This
finding makes the in vitro efficiency of TLc disputable. The
NCCLS has recently recommended 20–24 hours incuba-
tion for S. maltophilia, and so we did not evaluate the tests
after 48 hours incubation [9].
The correlations between in vitro susceptibility methods
for S. maltophilia show variations [10,14]. While Nico-
demo et al. [10] stated that the disc diffusion tests have an
excellent correlation with agar dilution for several antimi-
crobials; Pankuch et al. [14] used the breakpoint values
for Enterobacteriaceae recommended by the NCCLS and
found a high level of discordance for PTZ, TLc, CIP. Also,
in our study, poor agreement was observed in the alterna-
tive test methods except for SXT. In a study where the cor-
relation of E-test with agar dilution method for 16
antimicrobials in 176 clinical isolates were investigated,
the authors found an excellent correlation and recom-
mended E-test as an alternative susceptibility test [16].
Major and very major errors were very low in this latter
study and were similar to our results for all the antimicro-
bials except for CIP and CAZ by both the disc diffusion
and by the E-test. However most of the discordant suscep-
tibility rates among the three methods evaluated were due
to high occurrence of minor errors in our study. The MIC
values of our strains cumulated close to breakpoints. For
instance, the susceptibility breakpoint of CIP established
by the NCCLS is 1 mg/L [7] and equals to MIC50 value of
our strains. Moreover MIC values for CIP were 1 mg/L and
2 mg/L of 18 and 17 strains, respectively. The same applies
for CAZ and CPM also. Therefore, minor variations caused
to change in the susceptibility categories from intermedi-
ate susceptibility to susceptibility or resistance or vice
versa. If variations in ± 1 doubling dilutions between dif-
ferent methods were to be accepted as essential agreement
suggested by Pankuch et al [14] then our error rates would
have been much more smaller.
Tracking of S. maltophilia isolates has a great importance
to reveal their outbreaks, to determine the distribution
routes and to take preventive measures. However, biotyp-
ing and antibiotyping methods are not reliable due to the
relative metabolic inactivity and multiresistance of these
isolates. More recently, genotypic methods have been
developed and used with success to discriminate for phe-
notypically indistinguishable bacteria. AP-PCR is one of
the most preferred molecular typing methods for this aim,
because the results can be obtained rapidly even in a clin-
ical laboratory. Also, it can be applied to a wide range of
bacterial species by using almost the same materials and
equipment [2,13]. We determined two small outbreaks
consisting of five cases in the Neurology and three cases in
the Paediatrics clinics by using AP-PCR method. Isolation
dates, clinics, and antibiotyping data have also supported
these results. On the other hand, the third cluster (strains
from pattern III) suggests that the same strain can persistBMC Microbiology 2005, 5:24 http://www.biomedcentral.com/1471-2180/5/24
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for a long time in hospital. The first strain from pattern III
were isolated from the Pediatrics clinic in January 2001.
The second and third strains were isolated from the Neph-
rology clinic in August 2001 and from the Chest Diseases
clinic in November 2001, respectively. Reported nosoco-
mial outbreaks due to S. maltophilia are generally short
termed. [2]. There is no report of prolonged transmission
extending up to 11 months for S. maltophilia. Valdezate et
al [17] concluded that the epidemiological relationship
among different S. maltophilia isolates needed to be ana-
lysed because unexpected results could be obtained. Anti-
biotic susceptibility profiles also supported that isolates in
pattern III were independent isolates having same
genotypes.
Conclusion
In conclusion, the disc diffusion and the E-test methods
were unreliable alternative methods for S. maltophilia,
except for SXT. However, significance of these data should
be confirmed by further experimental and clinical studies.
Methods
Bacteria
The 52 S. maltophilia strains (one per patient) that were
isolated from nosocomial infections between 1998 and
2002 in the Hospital of Trakya University were included
in the study. The strains were identified by conventional
bacteriological methods and were stored at -70°C in
skim-milk media (Becton Dickinson, USA). Before the
study, they were twice passaged onto 5% sheep blood agar
and the identification was confirmed by Crystal ID
Enteric-nonfermenter (Becton Dickson, USA).
Antimicrobial susceptibility tests
The drug powders for the agar dilution test were obtained
from the following suppliers: Ceftazidime pentahydrate
(Glaxo-Welcome, UK), CPM (Bristol-Myers Squibb,
USA), PIP and tazobactam (Lederle, USA), ticarcillin dis-
odium and clavulanate lithium (GlaxoSmithKline, UK),
CIP (Bayer, Turkey), trimethoprim and sulfamethoxazole
(Roche, Turkey). Standard antimicrobial discs (Oxoid,
UK) were used for the disc diffusion tests and E-test strips
were supplied by AB Biodisk, Sweden.
Antimicrobial susceptibility tests were carried out using
the disc diffusion and agar dilution techniques as
described by NCCLS [7,8]. The Agar dilution and E-test
results were interpreted using the NCCLS criteria estab-
lished for non-enterobacteriaceae, and the disc diffusion
test was interpreted using the criteria established for P.
aeruginosa  [7-9]. The E-test technique was carried out
according to the manifacturer's instructions. The tests
were evaluated after 20–24 hours incubation at 35°C and
were repeated if they were found to be discordant.
Escherichia coli the American Type Culture Collection
(ATCC) 25922 and P. aeruginosa ATCC 27853 were used
as quality control strains.
Definitions
The agar dilution method was accepted as the reference
method. Categorical agreement was defined if the tests
results were within the same susceptibility category, and
errors of disc diffusion and E-test methods were deter-
mined as follows: Very major error; (resistant by reference
method, susceptible by test method); major error; (sus-
ceptible by reference method, resistant by test method);
and minor error; (intermediate result was obtained by one
method but not the other) [10]. Percentage errors were
calculated based on the total number of isolates which
were tested. A good agreement was defined as complete
category agreement over 90% and the total of very major
and major errors below 5% [11].
Arbitrarily primed PCR
The method of vanCouwenberghe et al. [12] was used for
the preparation of the DNA and AP-PCR, with minor
modifications. Briefly, after an overnight culture at 37°C
in 5% sheep blood agar, the bacteria were suspended in 1
ml TE buffer (10 mM Tris, 1 mM EDTA, pH: 8.0) to regu-
late the density to a 4 McFarland standard. Then, they
were heated at 100°C for 10 min. The suspension was
centrifuged at 2500 rpm for 10 minutes and the superna-
tant was used for AP-PCR. DNA in the supernatant was
quantitated by spectrophotometry at an optical density of
260 nm. PCR mixtures were prepared in 100 µl of 1X
buffer (10 mM Tris-HCl, 50 mM KCl, 2.5 mM MgCl2) and
contained 1 µg DNA, 0.1 mM each dNTP, 2.5 U Taq
polymerase and 30 pmol of pBR322 SalI primer (AGT-
CATGCCCCGCGC). PCR was initiated with five cycles of
low stringency, which included a denaturing step at 95°C
for 1 min, annealing of the primer at 28°C for 1 min, and
2 min of extension at 72°C. After the initial 5 cycles, 55
additional cycles were conducted with annealing of the
primer at 50°C. The reaction was terminated with a final
extension cycle at 72°C for 10 min.
Samples were electrophoresed in a 1.5% agarose gel
(Sigma, Germany) in 1X Tris-borate-EDTA buffer for 90
min at 100 V and visualized under UV light after staining
with ethidium bromide. To ensure reproducibility, all
amplifications were done in duplicate and were also
repeated using DNA extracted on different days. Dice coef-
ficients of similarity were calculated for every pair of iso-
lates by visual comparison of restriction patterns. If DNA
profiles of isolates were indistinguishable or differing by
only three or fewer DNA band shifts, then, the isolates
were deemed same or related and included in the same
pattern [13].Publish with BioMed Central    and   every 
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Statistical analysis
Chi-square test (Fisher's exact test when necessary) was
used.
Abreviations
SXT: Trimethoprim/sulfamethoxazole
CIP: Ciprofloxacin
MIC: Minimal inhibitory concentration
TLc: Ticarcillin/clavulanate
NCCLS: The National Committee for Clinical Laboratory
Standards
AP-PCR: The arbitrarily primed PCR
CAZ: Ceftazidime
CPM: Cefepime
PIP: Piperacillin
PTZ: Piperacillin/tazobactam
ATCC: The American Type Culture Collection
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